ACE2 and COVID-19: It can be concluded that factors that contribute to downregulation of ACE-2, dysregulation of RAAS, impairment of B- and T-cell immunity, and development of cytokine release syndrome also contribute to COVID-19 severity, ICU admission, ventilator aid, and mortality [22,24-27].